Management of Acute Severe Hepatitis or Acute Liver Failure in Children

Current Management Approach

The American Association for the Study of Liver Diseases recommends glucocorticoid therapy (prednisone or prednisolone alone, 0.5-1 mg/kg daily in adults and up to 2 mg/kg in children) as the first-line treatment for acute severe autoimmune hepatitis 1
For acute liver failure (ALF), immediate evaluation for liver transplantation is recommended rather than prolonged medical therapy, as indicated by the American Association for the Study of Liver Diseases 1, 2
Treatment response should be assessed within 1-2 weeks; failure to improve laboratory tests or clinical deterioration warrants immediate consideration for liver transplantation, according to the American Association for the Study of Liver Diseases 1, 2

Rapid improvement in serum aminotransferase levels within 2 weeks is the most important indicator of favorable outcome, as stated by the American Association for the Study of Liver Diseases 3
Failure to improve any laboratory test reflecting liver inflammation or function, especially hyperbilirubinemia, requires immediate consideration of liver transplantation, as recommended by the American Association for the Study of Liver Diseases 1
Hepatic encephalopathy at presentation defines ALF and indicates that liver transplantation is more likely to improve survival than protracted medical treatment, according to the American Association for the Study of Liver Diseases 1, 2

There is no mention of silymarin or L-ornithine L-aspartate in any of the major clinical practice guidelines for management of acute severe hepatitis or ALF in children, as noted by the American Association for the Study of Liver Diseases 1, 2, 4

For acute severe hepatitis in children, the American Association for the Study of Liver Diseases recommends beginning glucocorticoid therapy (prednisone/prednisolone up to 2 mg/kg daily) and monitoring laboratory tests and clinical status closely 1, 2
For acute liver failure in children, the American Association for the Study of Liver Diseases recommends proceeding directly to liver transplantation evaluation 1, 2

Silymarin and L-ornithine L-aspartate should not delay definitive treatment or transplantation evaluation in acute severe hepatitis or ALF, as warned by the American Association for the Study of Liver Diseases 1, 2
Close monitoring is essential as the condition can deteriorate rapidly, requiring prompt intervention, as emphasized by the American Association for the Study of Liver Diseases 5
Parents should be educated about warning signs requiring immediate medical attention, including jaundice, abdominal distension or pain, changes in mental status, unusual bleeding or bruising, persistent vomiting, and fever, as advised by the American Association for the Study of Liver Diseases 5